Key Highlights

  • Aehr Test Systems shares are trading down 14.71% today to $124.20, sliding from fresh 52-week highs near $147.
  • The pullback follows an 11-session AI-fueled rally, as investors book profits amid a broader risk-off tone in tech and semiconductors driven by surging Treasury yields and rising oil prices tied to Middle East tensions.
  • The sell-off comes despite continued insider selling by executives including the CEO and COO during the stock's steep run-up, alongside strong fundamentals, including fiscal 2027 guidance of $130 to $150 million in revenue, a $60.7 million backlog, and a recent $22 million follow-on order from its lead AI customer.
  • Analysts maintain a consensus 'Buy' rating, though the stock's elevated valuation is prompting some to question whether it has gotten ahead of itself.

What's Happening

Aehr Test Systems (NASDAQ:AEHR) shares are sliding sharply today, down more than 15% intraday, as investors book profits following an 11-session AI-fueled rally that had pushed the stock to fresh 52-week highs near $147. Aehr Test Systems, founded in 1977 and headquartered in Fremont, California, is a leading provider of wafer-level and package-level test and burn-in solutions for the semiconductor industry.

The company's core product families, including the FOX-XP, FOX-NP, FOX-CP, ABTS, and the newer Sonoma platform, enable manufacturers to test and stabilize a wide range of devices such as silicon carbide and gallium nitride power semiconductors, memory chips, processors, and electronic photonics used in electric vehicle, data center, and industrial applications. Aehr has positioned itself as a critical supplier to the growing SiC power device and AI/data infrastructure testing markets, benefiting from secular Demand for higher reliability and increased test capacity.

Profit-Taking Despite Strong Fundamentals

The pullback comes amid a broader risk-off tone in tech and semiconductors, driven by surging Treasury yields, which hit a 19-year high, and rising oil prices tied to Middle East tensions, alongside continued insider selling by executives including the CEO and COO during the stock's steep run-up. Despite the sell-off, Aehr's underlying fundamentals remain strong, with fiscal 2027 guidance of $130 million to $150 million in revenue, a $60.7 million backlog, and a recent $22 million follow-on order from its lead AI customer supporting a consensus 'Buy' rating, though the stock's elevated valuation is prompting some to question whether it has gotten ahead of itself following its steep run-up.

The Takeaway

Aehr Test Systems shares are sharply lower today as investors take profits following an extraordinary multi-session rally, even as the company's underlying order Backlog and Revenue guidance remain robust. With analysts maintaining a broadly bullish stance despite today's pullback, near-term direction will likely hinge on whether the stock's valuation can be supported by continued order momentum from its AI and semiconductor customers.